Stockscreener 앱 받기
4.64
2.11%
-0.10
시간 외 거래:
4.67
0.03
+0.65%
전일 마감가:
$4.74
열려 있는:
$4.81
하루 거래량:
253.08K
Relative Volume:
2.08
시가총액:
$81.37M
수익:
-
순이익/손실:
$-24.05M
주가수익비율:
-2.1581
EPS:
-2.15
순현금흐름:
$-17.78M
1주 성능:
-4.72%
1개월 성능:
+17.17%
6개월 성능:
+50.65%
1년 성능:
-9.02%
1일 변동 폭
$4.50
$4.87
1주일 범위
$4.50
$5.13
52주 변동 폭
$2.0278
$5.81
Envveno Medical Corporation Stock (NVNO) Company Profile
명칭
Envveno Medical Corporation
전화
949-261-2900
주소
70 DOPPLER, IRVINE
NVNO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
4.64 | 96.04M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Envveno Medical Corporation 주식(NVNO)의 최신 뉴스
What makes enVVeno Medical Corporation stock price move sharplyFree Real-Time Analysis With Entry Targets - Newser
Can swing trading help recover from enVVeno Medical Corporation lossesDeep Stock Performance and Volatility Analysis - Newser
Published on: 2025-08-10 20:29:48 - Newser
Is enVVeno Medical Corporation stock poised for growthShort-Term Sector Movement Forecast Generator - Newser
Tick level data insight on enVVeno Medical Corporation volatilityTrade Safety Matrix for Conservative Traders - Newser
Is enVVeno Medical Corporation trending in predictive chart modelsProfitable Trading Blueprint with Entry Zones - Newser
Is now a turning point for enVVeno Medical CorporationFast Entry Strategy with Price Prediction - Newser
How high can enVVeno Medical Corporation stock goFree Low Risk Buy Zone Opportunity Watch - Newser
Visual trend scoring systems applied to enVVeno Medical Corporation3-Year Equity Summary With Setup Insights - Newser
Will earnings trigger a reversal in enVVeno Medical CorporationEntry Optimization Tool with Screener Logic - Newser
How to forecast enVVeno Medical Corporation trends using time seriesSafe Investment Ideas with Growth Upside - Newser
Can volume confirm reversal in enVVeno Medical CorporationLow Risk Stock Trade Opportunity Analysis - Newser
Health Economic Study Shows That enVVeno Medical’s VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency - The Florida Times-Union
Health Economic Study Shows That enVVeno Medical's VenoValve(R) - GuruFocus
enVVeno Medical’s VenoValve shows cost-effectiveness for CVI treatment - Investing.com
Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency - ACCESS Newswire
VenoValve Study Shows $32,442 Cost Savings Per Patient in Chronic Venous Disease | NVNO Stock News - Stock Titan
Risk adjusted return profile for enVVeno Medical Corporation analyzedFree Daily Chart Pattern Stock Forecast - Newser
Why enVVeno Medical Corporation stock attracts strong analyst attentionTechnical Confirmation System with Signal Alerts - Newser
enVVeno Medical Participates in a New Virtual Investor “What This Means” Segment to Discuss How President Trump’s Recent CVI Diagnosis May Impact the Company - Knoxville News Sentinel
Price Action Confirms Reversal in enVVeno Medical Corporation TrendSmart Trade Plans With Risk Protection Explained - metal.it
enVVeno participates in ‘What This Means’ segment on Trump’s CVI diagnosis - TipRanks
enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company - ACCESS Newswire
Trump's CVI Diagnosis Could Make This Medical Device Company's FDA Decision More Significant - Stock Titan
Is it too late to sell enVVeno Medical CorporationHigh Return Strategy with Low Risk - Newser
enVVeno Medical Advances in Treating Severe CVI, Progressing with Innovative Therapies and FDA Approval Milestones. - AInvest
Published on: 2025-08-04 02:46:17 - Jammu Links News
How many analysts rate enVVeno Medical Corporation as a “Buy”Invest confidently with daily market forecasts - Jammu Links News
What are analysts’ price targets for enVVeno Medical Corporation in the next 12 monthsSuperior investment outcomes - Jammu Links News
What are enVVeno Medical Corporation company’s key revenue driversRapidly growing investment returns - Jammu Links News
What is the dividend policy of enVVeno Medical Corporation stockAchieve consistent double-digit returns - Jammu Links News
Does enVVeno Medical Corporation stock perform well during market downturnsGet timely alerts on market opportunities - Jammu Links News
How does enVVeno Medical Corporation generate profit in a changing economyDiscover high-impact investment opportunities - Jammu Links News
Envveno Medical Corporation (NVNO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):